Mid-Day Market Update: Dow Dips Over 100 Points; Sunshine Biopharma Shares Surge
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 100 points on Tuesday. The Dow traded down 0.33% to 34,805...
Stay updated with breaking news from Forte Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 100 points on Tuesday. The Dow traded down 0.33% to 34,805...
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 150 points on Tuesday. The Dow traded down 0.45% to 34,...
(2) DJ Imara reports Phase 2a clinical trial results of IMR-687 in adult patients with sickle cell disease Arix Bioscience PLC (ARIX) Imara reports Phase 2a clinical trial results of IMR-687 in adult patients with sickle cell disease 06-Jan-2021 / 14:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Arix Bioscience plc Imara reports Phase 2a clinical trial results of IMR-687 in adult patients with sickle cell disease LONDON, 06 January 2021: Arix Bioscience plc ("Arix", ...